NYSE:HQL (USA)
Tekla Life Sciences Investors
$
16.49
0.16 (0.98%)
| Volume: | 113,461 | Avg Vol (1m): | 89,641 |
| Market Cap $: | 375.23 Mil | Enterprise Value $: | 375.23 Mil |
| P/E (TTM): | 5.04 | P/B: | 0.00 |
| Earnings Power Value | 0 |
| Net Current Asset Value | 0 |
| Tangible Book | 0 |
| Projected FCF | 0 |
| Median P/S Value | 0 |
| Graham Number | 0 |
| Peter Lynch Value | 0 |
| DCF (FCF Based) | 0 |
| DCF (Earnings Based) | 0 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 5/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Interest Coverage | No Debt |
Interest Coverage ranked
lower than
100.00%
of
938
companies
in the
Asset Management
industry.
Industry Max: 80954, Med: 9999, Min: 0.07
HQL:
No Debt
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 0, Med: 0, Max: 10000
Current: 10000
|
Profitability & Growth : 2/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history |
|---|
» HQL's 30-Y Financials
Financials (Next Earnings Date: 2019-05-31)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:HQL
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Asset Management » Asset Management NAICS : 523930 SIC : 6282 |
| Compare | LSE:HHI MIL:CALT XSGO:NITRATOS XKRX:041190 LSE:JAI LSE:LAHL ASX:NGI LSE:ELTA ASX:PMC MIL:DEA LSE:JPE LSE:THRG LSE:OCI MIC:UCSS LSE:PSDL NAS:BKCC LSE:AAS XSWX:CPEN LSE:SLS XPAR:ABCA |
| Traded in other countries | |
| Address | 100 Federal Street, 19th Floor, Boston, MA, USA, 02110 |
| Tekla Life Sciences Investors, formerly known as H&Q Life Sciences Investors is a closed-end management investment company. Its investment objective is long-term capital appreciation through investment in U.S. and foreign companies in the life sciences industry, agriculture and environmental management. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 5.04 |
PE Ratio ranked
lower than
100.00%
of
810
companies
in the
Asset Management
industry.
Industry Max: 10330.11, Med: 12.95, Min: 0
HQL:
5.04
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 0, Med: 0, Max: 6.74
Current: 5.04
|
| PE Ratio without NRI | 5.04 |
PE without NRI ranked
lower than
100.00%
of
787
companies
in the
Asset Management
industry.
Industry Max: 10330.11, Med: 13.2, Min: 0.01
HQL:
5.04
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 0, Med: 0, Max: 6.74
Current: 5.04
|
| EV-to-EBIT | 5.05 |
EV-to-EBIT ranked
lower than
100.00%
of
618
companies
in the
Asset Management
industry.
Industry Max: 209280.07, Med: 11.02, Min: 0.03
HQL:
5.05
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: 0, Med: 0, Max: 6.81
Current: 5.05
|
| EV-to-EBITDA | 5.05 |
EV-to-EBITDA ranked
lower than
100.00%
of
644
companies
in the
Asset Management
industry.
Industry Max: 209280.07, Med: 10.43, Min: 0.03
HQL:
5.05
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: 0, Med: 0, Max: 6.81
Current: 5.05
|
| EV-to-Revenue | 4.90 |
EV-to-Revenue ranked
lower than
100.00%
of
915
companies
in the
Asset Management
industry.
Industry Max: 73227.5, Med: 4.87, Min: 0.02
HQL:
4.9
Ranked among companies with meaningful EV-to-Revenue only.
| N/A |
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| Dividend Yield % | 9.39 |
Trailing Dividend Yield ranked
lower than
100.00%
of
1130
companies
in the
Asset Management
industry.
Industry Max: 1040.72, Med: 4.62, Min: 0.01
HQL:
9.39
Ranked among companies with meaningful Trailing Dividend Yield only.
|
Trailing Dividend Yield range over the past 10 years
Min: 0, Med: 0, Max: 9.77
Current: 9.39
|
| Dividend Payout Ratio | 1.33 |
Dividend Payout Ratio ranked
lower than
100.00%
of
597
companies
in the
Asset Management
industry.
Industry Max: 642.11, Med: 0.62, Min: 0.01
HQL:
1.33
Ranked among companies with meaningful Dividend Payout Ratio only.
|
Dividend Payout Ratio range over the past 10 years
Min: 0, Med: 0, Max: 1.33
Current: 1.33
|
| Forward Dividend Yield % | 9.06 |
Forward Dividend Yield ranked
lower than
100.00%
of
1041
companies
in the
Asset Management
industry.
Industry Max: 908.54, Med: 4.97, Min: 0.01
HQL:
9.06
Ranked among companies with meaningful Forward Dividend Yield only.
| N/A |
| Yield-on-Cost (5-Year) % | 9.39 |
Yield-on-Cost (5y) ranked
lower than
100.00%
of
1108
companies
in the
Asset Management
industry.
Industry Max: 1040.72, Med: 5.2, Min: 0.01
HQL:
9.39
Ranked among companies with meaningful Yield-on-Cost (5y) only.
|
Yield-on-Cost (5y) range over the past 10 years
Min: 0, Med: 0, Max: 9.77
Current: 9.39
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Earnings Yield (Joel Greenblatt) % | 19.35 |
Earnings Yield (Greenblatt) ranked
lower than
100.00%
of
1023
companies
in the
Asset Management
industry.
Industry Max: 3562.78, Med: 3.2, Min: -5000
HQL:
19.35
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: 0, Med: 0, Max: 22.76
Current: 19.35
|
More Statistics
| Revenue (TTM) (Mil) $ | 74.12 |
| EPS (TTM) $ | 3.21 |
| Beta | 1.48 |
| Volatility % | 28.95 |
| 52-Week Range $ | 13.95 - 20.68 |
| Shares Outstanding (Mil) | 22.76 |